Dublin, Dec. 03, 2024 (GLOBE NEWSWIRE) — The “Stem Cell Manufacturing – Global Strategic Business Report” has been added to ResearchAndMarkets.com’s offering.
The global market for Stem Cell Manufacturing was estimated at US$13.5 Billion in 2023 and is projected to reach US$23 Billion by 2030, growing at a CAGR of 7.9% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.
The growth in the Stem Cell Manufacturing market is driven by several factors, including increasing demand for regenerative therapies that address unmet medical needs across various diseases, such as cardiovascular, neurological, and autoimmune disorders. Advancements in cell culture techniques, bioreactors, and automation have improved scalability, consistency, and cost-effectiveness in stem cell production, supporting broader clinical and commercial applications.
The focus on personalized medicine and targeted treatments has further fueled demand, as stem cells enable customized therapies based on individual patient profiles. Additionally, rising investments in biotechnology research, supportive government regulations, and growing collaboration between research institutes and biopharma companies have contributed to market growth, encouraging large-scale stem cell manufacturing for diverse medical applications.
Scope of the Study
The report analyzes the Stem Cell Manufacturing market, presented in terms of market value (US$ Million). The analysis covers the key segments outlined below.
Segments
- Product (Culture Media, Consumables, Instruments, Stem Cell Lines
- Application (Research-based, Cell & Tissue Banking, Clinical-based)
Key Insights:
- Market Growth: Understand the significant growth trajectory of the Culture Media segment, which is expected to reach US$9.2 Billion by 2030 with a CAGR of a 7.7%. The Consumables segment is also set to grow at 8% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, estimated at $3.6 Billion in 2023, and China, forecasted to grow at an impressive 7.4% CAGR to reach $3.6 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Stem Cell Manufacturing Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Stem Cell Manufacturing Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Stem Cell Manufacturing Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of major players in the Global Stem Cell Manufacturing Market such as Anterogen, Becton, Dickinson and Company, Bio-Rad Laboratories, Cellular Dynamics International, Holostem Terapie Avanzate and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 89 |
| Forecast Period | 2023 – 2030 |
| Estimated Market Value (USD) in 2023 | $13.5 Billion |
| Forecasted Market Value (USD) by 2030 | $23 Billion |
| Compound Annual Growth Rate | 7.9% |
| Regions Covered | Global |
Key Topics Covered:
MARKET OVERVIEW
- World Market Trajectories
- Global Economic Update
- Stem Cell Manufacturing – Global Key Competitors Percentage Market Share in 2024 (E)
- Competitive Market Presence – Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
MARKET TRENDS & DRIVERS
- Rising Demand for Autologous and Allogeneic Stem Cell Therapies Spurs Market Growth
- Advancements in Bioprocessing Technologies Propel Manufacturing Capabilities
- Expansion of Cell and Gene Therapy Expands Addressable Market
- Growing Use of Stem Cells in Drug Development Strengthens Business Case
- Rising Focus on Personalized Medicine Drives Adoption of Stem Cell Manufacturing
- Increasing Use in Disease Modeling and Tissue Engineering Fuels Growth
- Emergence of Automated Cell Culture Technologies Expands Opportunities
- Rising Focus on Oncology and Cardiovascular Applications Spurs Adoption
- Emergence of 3D Culture Technologies Strengthens Market Growth
- Rising Need for Scalable Manufacturing Solutions Accelerates Demand
- Increasing Use of Stem Cells in Regenerative Orthopedics Propels Manufacturing
FOCUS ON SELECT PLAYERS
- Anterogen
- Becton, Dickinson and Company
- Bio-Rad Laboratories
- Cellular Dynamics International
- Holostem Terapie Avanzate
- Lonza Group
- Medipost
- Merck Group
- Miltenyi Biotec
- Osiris Therapeutics
- Pharmicell
- Pluristem Therapeutics
- Stemcell Technologies
- Takara Bio Group
- Thermo Fisher Scientific
For more information about this report visit https://www.researchandmarkets.com/r/x6mf0u
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
- Stem Cell Manufacturing Market
